Misako Kunii Selected Research

Misako Kunii Research Topics

Disease

3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 10/2019
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 01/2018
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 10/2019
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2021
1	Neurosarcoidosis 11/2021
1	Spontaneous Fractures (Pathological Fracture) 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021
1	Osteoporosis 01/2021
1	Multiple System Atrophy 01/2021
1	Disease Progression 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Cognitive Dysfunction 01/2021
1	Bone Fractures (Bone Fracture) 01/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Bone Resorption 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Necrosis 12/2020
1	Neurodevelopmental Disorders 09/2020
1	Meningitis 08/2020
1	Sinusitis 08/2020
1	Subdural Effusion (Subdural Hygroma) 08/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Nephritis 01/2020
1	Rheumatoid Arthritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2020
1	Tonsillitis 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Vaccinia 09/2019
1	Multiple Sclerosis 02/2018
1	Inflammation (Inflammations) 02/2018
1	Neuroinflammatory Diseases 02/2018
1	Nervous System Diseases (Neurological Disorders) 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2015
1	Central Nervous System Lupus Vasculitis 02/2013
1	Hashimoto's encephalitis 02/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	AntibodiesIBA 11/2021 - 02/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2018
1	Cholinergic ReceptorsIBA 11/2021
1	polyglutamineIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	GonadotropinsIBA 01/2021
1	RNA Polymerase IIIIBA 01/2021
1	RANK LigandIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Hepatitis B Core AntigensIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Signal Recognition ParticleIBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Calcium Channels (Calcium Channel)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 09/2019
1	LipopolysaccharidesIBA 02/2018
1	Nogo Receptor 1IBA 02/2018
1	Messenger RNA (mRNA)IBA 02/2018
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 04/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2018
1	Decompression 08/2020
1	Craniotomy 08/2020
1	Tonsillectomy 01/2020
1	Immunotherapy 02/2013